Trial Profile
CCRC: A pilot project of virologic, pharmacologic and immunologic correlates of gastrointestinal-associated lymphoid tissue immune reconstitution following raltegravir therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Efavirenz; Emtricitabine/tenofovir disoproxil fumarate; Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
- Indications HIV infections
- Focus Pharmacodynamics
- Acronyms CCRC
- 03 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.
- 24 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.